Besides, increased IAPP is detected in the cerebrospinal fluid (CSF) of AD patients with or without apparent T2DM [18], as well as in the temporal lobe gray matter in patients with T2DM [19, 20], indicating that circulating IAPP can cross the blood-brain barrier (BBB) and deposit in the brain. The gene discussed is IAPP; the disease is Alzheimer disease.